ADVERTISEMENT
search.svg

Pharmacy News

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

CDC releases guidance on caring for ‘COVID long-haulers’

Thousands of patients have reported experiencing a wide range of physical and mental health consequences that persist after a COVID-19 infection. Patients with post-COVID-19 conditions, sometimes referred to as “COVID long-haulers,” often experience issues four or more weeks after being infected with the virus. Many of these patients routinely seek medical treatment for relief of their symptoms.

What might this flu season have in store?

Influenza cases and deaths in the United States and worldwide dropped to unprecedented lows between October 3, 2020, and July 24, 2021, according to CDC data. In a typical season, 75 to 150 children die of influenza in the United States, noted pediatric infectious disease specialist Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia, in a recent JAMA Network article. Last influenza season, he said, one child was reported to have died.

Pharmacists poised to address unmet mental health needs

Among the many collateral effects of COVID-19, the pandemic has exacerbated the mental health crisis in the United States. For some, the global shutdown interrupted ongoing mental health care. For others, the stress and isolation triggered new mental health issues. 

Flu vaccine can protect against severe effects of COVID-19, study finds

A new study published in PLoS One suggests that the influenza vaccine may help safeguard individuals against COVID-19.

RSS
123